gms | German Medical Science

27. Deutscher Krebskongress

Deutsche Krebsgesellschaft e. V.

22. - 26.03.2006, Berlin

Are breast cancer women different? – Results from the 2004 PAtient Satisfaction and Quality in Oncological Care (PASQOC®) study

Meeting Abstract

Suche in Medline nach

  • corresponding author presenting/speaker Petra Feyer - Vivantes Clinic Neukoelln, Berlin, Deutschland
  • Monika Behrens - GlaxoSmithKline GmbH & Co. KG
  • Iris Heiden - Picker Institut, Hamburg

27. Deutscher Krebskongress. Berlin, 22.-26.03.2006. Düsseldorf, Köln: German Medical Science; 2006. DocOP536

Die elektronische Version dieses Artikels ist vollständig und ist verfügbar unter:

Veröffentlicht: 20. März 2006

© 2006 Feyer et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen ( Er darf vervielfältigt, verbreitet und öffentlich zugänglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.



The study on PAtient Satisfaction and Quality in Oncological Care (PASQOC®) 2002 was the first assessment in Germany focussing directly on patient satisfaction in oncological care. In 2004 PASQOC® was executed again, this time also focussing on breast cancer patients.

Objective: Compare women with breast cancer (WBCa) to women with other tumour types (WOT).

Method: To assess and observe quality of oncological ambulatory (out-patient) care, the formally validated questionnaire PASQOC® was distributed to all cancer patients presenting at the investigators’ practices within a defined recruiting period. Inclusion criteria: German speaking, ≥18 years, confirmed cancer diagnosis, physical/mental ability to complete a self-administered questionnaire. Analysis of PASQOC®: dichotomous 'problem scores' indicating presence/absence of a problem, with lower scores marking fewer problems (scale range: 0-100). Summed into 13 'dimension scores', each clustering a defined set of questions.

Results: The 49 practices recruited n=2617 women, 43.3 % with breast cancer (BCa); mean age with BCa: 59.9 years (others: 64.0 years; p≤0.001). Samples differed significantly in structure, eg. therapy goal, status of employment etc. WBCa reported on average more problems than WOT in all 13 dimensions but “communication with other patients”. Differences were highly significant (p≤0.01) for patient-physician relationship (WBCa: 10.6; WOT: 8.3), communication with physicians (21.6; 19.1), handling of side effects (41.4; 36.6), involvement of family members and friends (19.4; 15.3) and need for further information (21.4; 18.9). WBCa showed particular concern in respect to information on impact on sexual life (42.7; 37.0) as well as consideration of family situation (21.5; 17.0). Furthermore, WBCa reported a greater need for information on therapy related side-effects. There is evidence that WBCa age 40≤49 report more problems compared to WOT than other age groups as do WBCa with chemo-/radiotherapy.

Conclusion: The PASQOC® questionnaire is a tool to detect differences in patient perception of quality of care in defined patient populations. Based on the hypothesis that all female cancer patients are cared for in the same way, we can conclude that WBCa perceive some of those services provided by professional care givers as more inefficient and are less satisfied than WOT (and vice versa). The next step is to identify levers and develop means of action for all women suffering from cancer.